These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 1356625)

  • 41. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
    Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
    Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.
    Satoh Y; Nakadate H; Nakagawachi T; Higashimoto K; Joh K; Masaki Z; Uozumi J; Kaneko Y; Mukai T; Soejima H
    Br J Cancer; 2006 Aug; 95(4):541-7. PubMed ID: 16909133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Localization of a novel t(1;7) translocation associated with Wilms' tumor predisposition and skeletal abnormalities.
    Reynolds PA; Powlesland RM; Keen TJ; Inglehearn CF; Cunningham AF; Green ED; Brown KW
    Genes Chromosomes Cancer; 1996 Nov; 17(3):151-5. PubMed ID: 8946193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.
    Grundy RG; Pritchard J; Scambler P; Cowell JK
    Oncogene; 1998 Jul; 17(3):395-400. PubMed ID: 9690521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A clinical overview of WT1 gene mutations.
    Little M; Wells C
    Hum Mutat; 1997; 9(3):209-25. PubMed ID: 9090524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Familial predisposition to Wilms tumor does not segregate with the WT1 gene.
    Schwartz CE; Haber DA; Stanton VP; Strong LC; Skolnick MH; Housman DE
    Genomics; 1991 Aug; 10(4):927-30. PubMed ID: 1655633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
    Mannens M; Devilee P; Bliek J; Mandjes I; de Kraker J; Heyting C; Slater RM; Westerveld A
    Cancer Res; 1990 Jun; 50(11):3279-83. PubMed ID: 2159377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Wilms' tumour as a paradigm for the relationship of cancer to development.
    Pritchard-Jones K; Hastie ND
    Cancer Surv; 1990; 9(3):555-78. PubMed ID: 1966278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Nephroblastoma (Wilms' tumor): cytogenetic and molecular biology principles].
    Strohmeyer T
    Klin Padiatr; 1993; 205(3):135-9. PubMed ID: 8394474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytogenetics and molecular genetics of Wilms' tumor of childhood.
    Slater RM; Mannens MM
    Cancer Genet Cytogenet; 1992 Jul; 61(2):111-21. PubMed ID: 1322233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular genetics of Wilms' tumour.
    Tay JS
    J Paediatr Child Health; 1995 Oct; 31(5):379-83. PubMed ID: 8554853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis.
    Austruy E; Candon S; Henry I; Gyapay G; Tournade MF; Mannens M; Callen D; Junien C; Jeanpierre C
    Genes Chromosomes Cancer; 1995 Dec; 14(4):285-94. PubMed ID: 8605117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma.
    Henry I; Grandjouan S; Couillin P; Barichard F; Huerre-Jeanpierre C; Glaser T; Philip T; Lenoir G; Chaussain JL; Junien C
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3247-51. PubMed ID: 2566168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours.
    Mannens M; Slater RM; Heyting C; Bliek J; de Kraker J; Coad N; de Pagter-Holthuizen P; Pearson PL
    Hum Genet; 1988 Dec; 81(1):41-8. PubMed ID: 2848758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular genetic analysis of chromosome 11p in familial Wilms tumour.
    Baird PN; Pritchard J; Cowell JK
    Br J Cancer; 1994 Jun; 69(6):1072-7. PubMed ID: 7911030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allelic loss on chromosome 11p is a less frequent event in bilateral than in unilateral Wilms' tumours.
    Little MH; Clarke J; Byrne J; Dunn R; Smith PJ
    Eur J Cancer; 1992; 28A(11):1876-80. PubMed ID: 1356388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wilms tumor genetics.
    Huff V
    Am J Med Genet; 1998 Oct; 79(4):260-7. PubMed ID: 9781905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Germline and somatic abnormalities of chromosome 7 in Wilms' tumor.
    Wilmore HP; White GF; Howell RT; Brown KW
    Cancer Genet Cytogenet; 1994 Oct; 77(2):93-8. PubMed ID: 7954327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells.
    Reeve AE; Sih SA; Raizis AM; Feinberg AP
    Mol Cell Biol; 1989 Apr; 9(4):1799-803. PubMed ID: 2542777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.